Regeneron Pharmaceuticals shares owned by Capital Investment Counsel
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Capital Investment Counsel
from 13F filings
Historical chart of Capital Investment Counsel investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Capital Investment Counsel consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Capital Investment Counsel
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $303k | 288 | 1051.24 |
| 2024-06-30 | $303k | 288 | 1051.03 |
| 2024-03-31 | $277k | 288 | 962.49 |
| 2023-12-31 | $253k | 288 | 878.29 |
| 2023-09-30 | $237k | 288 | 822.96 |
| 2023-06-30 | $297k | 413 | 718.54 |
| 2023-03-31 | $329k | 400 | 821.67 |
| 2022-12-31 | $289k | 400 | 721.49 |
| 2022-09-30 | $207k | 300 | 690.00 |
| 2022-06-30 | $236k | 400 | 590.00 |
| 2022-03-31 | $244k | 350 | 697.14 |
| 2021-12-31 | $205k | 325 | 630.77 |
| 2018-06-30 | $250k | 725 | 344.83 |
| 2017-09-30 | $235k | 525 | 447.62 |
| 2017-06-30 | $258k | 525 | 491.43 |
| 2017-03-31 | $223k | 575 | 387.83 |
| 2016-12-31 | $211k | 575 | 366.96 |
| 2016-09-30 | $386k | 960 | 402.08 |
More positions owned by Capital Investment Counsel
View all positions for Capital Investment Counsel